An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man

International Journal of Urology

Volumn 16, Issue 3, 2009, Pages 333-335

  Koie, Takuya ^a,b   Yoneyama, Takahiro ^b   Hashimoto, Yasuhiro ^b   Kamimura, Noritaka ^b   Kusumi, Tomomi ^b   Kijima, Hiroshi ^b   Ohyama, Chikara ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Renal cell carcinoma; Xp11 translocation; Young adult

Indexed keywords

ANTIBODY; EOSIN; HEMATOXYLIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TFE2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACKACHE; CASE REPORT; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; COMPUTER ASSISTED TOMOGRAPHY; CYTOPLASM; DIAGNOSTIC ACCURACY; FEVER; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY MASS; MALE; MORTALITY; NEPHRECTOMY; NUCLEOLUS; PRIORITY JOURNAL; TUMOR CELL; TUMOR RECURRENCE; XP11 TRANSLOCATION RENAL CELL CARCINOMA;

ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, X; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FATAL OUTCOME; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; NEOPLASM INVASIVENESS; TRANSLOCATION, GENETIC;

EID: 62149105100     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02231.x     Document Type: Article

References (11)

1. Argani P, Faria M. Translocation carcinomas of the kidney. Clin. Lab. Med. 2005 25 : 363 78.
2. Argani P, Olgac S, Tickoo SK et al. Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum. Am. J. Surg. Pathol. 2007 31 : 1149 60.
3. Argani P, Ladanyi M. Renal carcinomas associated with xp11.2 translocations/tfe3 gene fusions. In : Eble JN, Sauter G, Epstein JI et al. (eds). Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, France, 2004 37 8.
4. Bruder E, Passera O, Harms D et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 2004 28 : 1117 32.
5. Cao Y, Paner GP, Perry KT et al. Renal neoplasms in younger adults: Analysis of 112 tumors from a single institution according to the new World Health Organization classification and 2002 American Joint Committee on Cancer Staging System. Arch. Pathol. Lab. Med. 2005 129 : 487 91.
6. Skalsky YM, Ajuh PM, Parker C et al. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors. Oncogene 2001 20 : 178 87.
7. Rais-Bahrami S, Drabick JJ, De Marzo AM et al. Xp11 translocation renal cell carcinoma: Delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology 2007 70 : 178.
8. Meyer PN, Clark JI, Flanigan RC, Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am. J. Clin. Pathol. 2007 128 : 70 9.
9. Tomlinson GE, Nisen PD, Timmons CF et al. Cytogenetics of a renal cell carcinoma in a 17-month-old child: Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet. Cytogenet. 1991 57 : 11 17.
10. Allory Y, Ouazana D, Boucher E et al. Papillary renal cell carcinoma. Prognostic value of morphologic subtypes in a clinicopathologic study of 43 cases. Virchows Arch. 2003 442 : 336 42.
11. Argani P, Lal P, Hutchinson B et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 fusions: A sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 2003 27 : 750 61.